Given MTT assay is a comprehensive evaluation of viable cells resulted from proliferation and survival, these studies showed that USP7 promotes CML cell survival and/or proliferation. The gene discussed is USP7; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.